+

WO2007048223A3 - Systeme d'administration de medicaments a retention gastrique - Google Patents

Systeme d'administration de medicaments a retention gastrique Download PDF

Info

Publication number
WO2007048223A3
WO2007048223A3 PCT/CA2006/001706 CA2006001706W WO2007048223A3 WO 2007048223 A3 WO2007048223 A3 WO 2007048223A3 CA 2006001706 W CA2006001706 W CA 2006001706W WO 2007048223 A3 WO2007048223 A3 WO 2007048223A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery system
drug delivery
gastric retention
matrix component
intermingled
Prior art date
Application number
PCT/CA2006/001706
Other languages
English (en)
Other versions
WO2007048223A2 (fr
Inventor
Jack Aurora
Vinayak Sant
Original Assignee
Pharmascience Inc
Jack Aurora
Vinayak Sant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2524422 external-priority patent/CA2524422A1/fr
Priority claimed from US11/257,361 external-priority patent/US20070092565A1/en
Application filed by Pharmascience Inc, Jack Aurora, Vinayak Sant filed Critical Pharmascience Inc
Priority to EP06804634A priority Critical patent/EP1957052A2/fr
Publication of WO2007048223A2 publication Critical patent/WO2007048223A2/fr
Publication of WO2007048223A3 publication Critical patent/WO2007048223A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un système d'administration de médicaments à rétention gastrique (c.-à-d. une forme pharmaceutique à libération contrôlée) formulé pour favoriser la rétention de la forme pharmaceutique dans le tractus gastro-intestinal supérieur et en particulier dans l'estomac.
PCT/CA2006/001706 2005-10-25 2006-10-17 Systeme d'administration de medicaments a retention gastrique WO2007048223A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06804634A EP1957052A2 (fr) 2005-10-25 2006-10-17 Systeme d'administration de medicaments a retention gastrique

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CA 2524422 CA2524422A1 (fr) 2005-10-25 2005-10-25 Dispositif d'administration de medicament a retention gastrique
US11/257,361 2005-10-25
CA2,524,422 2005-10-25
US11/257,361 US20070092565A1 (en) 2005-10-25 2005-10-25 Gastric retention drug delivery system

Publications (2)

Publication Number Publication Date
WO2007048223A2 WO2007048223A2 (fr) 2007-05-03
WO2007048223A3 true WO2007048223A3 (fr) 2007-06-14

Family

ID=37968169

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2006/001706 WO2007048223A2 (fr) 2005-10-25 2006-10-17 Systeme d'administration de medicaments a retention gastrique

Country Status (2)

Country Link
EP (1) EP1957052A2 (fr)
WO (1) WO2007048223A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010143052A1 (fr) * 2009-06-12 2010-12-16 Micro Labs Limited Nouvelles compositions pharmaceutiques contenant de la prégabaline
EP2361615A1 (fr) 2010-02-19 2011-08-31 Alfred E. Tiefenbacher GmbH & Co. KG Comprimé à libération prolongée de dipyridamole
MX2012013021A (es) * 2010-05-11 2012-12-17 Cima Labs Inc Formulaciones resistentes a alcohol.
EP2415460A1 (fr) * 2010-08-03 2012-02-08 ratiopharm GmbH Formulations pour l'administration orale de prégabaline
WO2013109199A1 (fr) * 2011-12-19 2013-07-25 Mahmut Bilgic Formulations pharmaceutiques effervescentes comprenant de la prégabaline et de la vitamine b12
WO2013100874A1 (fr) * 2011-12-19 2013-07-04 Mahmut Bilgic Formulation de prégabline effervescente
EP2698144A1 (fr) * 2012-08-12 2014-02-19 Ali Raif Ilaç Sanayi ve Ticaret Anonim Sirketi Formulation de comprimé à libération prolongée contenant de la gabapentine dont l'aptitude à rester dans l'estomac est améliorée
WO2015114509A1 (fr) * 2014-01-28 2015-08-06 Ranbaxy Laboratories Limited Comprimés à rétention gastrique stabilisée de prégabaline
CA2951909C (fr) 2014-06-11 2022-08-16 Massachusetts Institute Of Technology Dispositifs a demeure auto-assembles, et procedes associes
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
CN107592803B (zh) 2015-05-01 2021-01-22 麻省理工学院 可触发形状记忆感应装置
EP3364946A4 (fr) 2015-10-23 2019-06-26 Lyndra, Inc. Systèmes à demeure gastriques pour libération prolongée d'agents thérapeutiques et leurs procédés d'utilisation
JP7030052B2 (ja) 2015-12-08 2022-03-04 リンドラ セラピューティクス， インコーポレイティド 胃滞留システムのための幾何学的構成
CN109310639A (zh) 2016-05-27 2019-02-05 林德拉有限公司 用于胃驻留系统的材料结构
EP3518902A4 (fr) 2016-09-30 2020-07-08 Lyndra, Inc. Systèmes de résidence gastrique permettant l'administration prolongée de médicaments de la classe de l'adamantane
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
CN113521023B (zh) * 2021-07-16 2023-04-25 昆明理工大学 一种紫胶树脂基胃内漂浮滞留载药系统的制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941064A1 (fr) * 1996-11-17 1999-09-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem PREPARATIONS PHARMACEUTIQUES SERVANT A EFFECTUER LA LIBERATION CONTROLEE D'ANTIBIOTIQUES DE beta-LACTAME
CA2452738A1 (fr) * 2001-07-04 2003-02-13 Sun Pharmaceutical Industries Limited Systeme d'administration regulee de medicament a retention gastrique
WO2003026637A2 (fr) * 2001-09-28 2003-04-03 Sun Pharmaceutical Industries Limited Forme posologique pour traiter le diabete sucre
WO2004032906A1 (fr) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Forme gastro-retentive pour administrer du levodopa
US6861072B1 (en) * 1998-10-16 2005-03-01 Sanofi-Synthelabo Pharmaceutical composition with gastric residence and controlled release
WO2005060942A1 (fr) * 2003-12-19 2005-07-07 Aurobindo Pharma Ltd Composition pharmaceutique de metformine a liberation prolongee
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
US20060165745A1 (en) * 2005-01-21 2006-07-27 Yiwen Chew Sustained release tablets for treatment of aqueous environment and methods for making the same

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941064A1 (fr) * 1996-11-17 1999-09-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem PREPARATIONS PHARMACEUTIQUES SERVANT A EFFECTUER LA LIBERATION CONTROLEE D'ANTIBIOTIQUES DE beta-LACTAME
US6861072B1 (en) * 1998-10-16 2005-03-01 Sanofi-Synthelabo Pharmaceutical composition with gastric residence and controlled release
CA2452738A1 (fr) * 2001-07-04 2003-02-13 Sun Pharmaceutical Industries Limited Systeme d'administration regulee de medicament a retention gastrique
WO2003026637A2 (fr) * 2001-09-28 2003-04-03 Sun Pharmaceutical Industries Limited Forme posologique pour traiter le diabete sucre
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
WO2004032906A1 (fr) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Forme gastro-retentive pour administrer du levodopa
WO2005060942A1 (fr) * 2003-12-19 2005-07-07 Aurobindo Pharma Ltd Composition pharmaceutique de metformine a liberation prolongee
US20060165745A1 (en) * 2005-01-21 2006-07-27 Yiwen Chew Sustained release tablets for treatment of aqueous environment and methods for making the same

Also Published As

Publication number Publication date
EP1957052A2 (fr) 2008-08-20
WO2007048223A2 (fr) 2007-05-03

Similar Documents

Publication Publication Date Title
WO2007048223A3 (fr) Systeme d'administration de medicaments a retention gastrique
WO2007013975A3 (fr) Compositions et procedes destines a controler l'abus de medicaments
WO2007044906A3 (fr) Préparations et méthodes pour l'augmentation de la stabilité gastro-intestinale d'oligopeptides et de polypeptides
AR062583A1 (es) Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan
WO2008060964A3 (fr) Procédés d'administration de médications pour la perte de poids
WO2010062688A3 (fr) Forme galénique pour insertion dans la bouche
WO2006084164A8 (fr) Systeme d'administration a retention gastrique et a liberation lente
WO2006035417A3 (fr) Preparations de dihydropyrimidine
EP2792349A3 (fr) Compositions pharmaceutiques à libération contrôlée comportant un ester d'acide fumarique
EP3895699A3 (fr) Compositions pharmaceutiques contenant de l'oxyhroxyde de fer
WO2006039022A3 (fr) Administration orale regionale controlee
MY147641A (en) Fast release paracetamol tablets
MX2009011275A (es) Una composicion de microesferas biodegradables adecuadas para la liberacion controlada de peptido de control de la glucosa y formulacion de la misma.
WO2008049657A3 (fr) Utilisation de copolymères de (méth)acrylate dans des formes de médicaments à délivrance retardée pour diminuer les effets de l'éthanol sur la libération de la subtance active
WO2004064815A8 (fr) Formulation de dosage oral
WO2010103365A3 (fr) Composition à libération lente d'un agent thérapeutique
WO2009051022A3 (fr) Préparation pharmaceutique solide
CL2007002000A1 (es) Preparacion farmaceutica para la administracion oral con liberacion controlada de ingrediente activo en el intestino delgado que comprende portadores inertes, ingredientes activo, una capa interna compuesta de 2 capas de difusion para controlar la liberacion y una capa gastrorresistente; metodo de preparacion.
WO2007035515A3 (fr) Procede d'augmentation d'une exposition intraepitheliale et systemique a des agents therapeutiques ayant une activite de substrat pour les enzymes p450 cytochromes, et systemes d'ecoulements membranaires par voie vaginale ou orale
WO2007144169A3 (fr) Dérivés d'entacapone
WO2007025182A3 (fr) Compositions de medicament renfermant des matrices d'hypermellose a liberation commandee
WO2010027404A3 (fr) Formulation stable de polypeptides thérapeutiques pour une administration par voie orale
GEP20104896B (en) Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
WO2005112896A3 (fr) Forme posologique permettant l'administration de multiples formes medicamenteuses
NZ591408A (en) Paracetamol and Calcium carbonate composition

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2006804634

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006804634

Country of ref document: EP

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载